Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
K.SinkeyC
The other authors report no conflicts of interest
Transglutaminase 2 expression predicts progression free survival in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor
Associations of ferritin and folate status with clinical outcomes in childhood cancer patients: a Prospective Cohort study
Oxyntomodulin analogue increases energy expenditure via the Gcg receptor
Upon initiating therapy, the endocrinologist ensures appropriate dose titration to minimise GI side effects, provides education on injection technique and timing, and establishes therapeutic goals, such as glycaemic control, weight reduction, and improvement in cardiometabolic risk
